Empowering frontline doctors heroes with AI

Biocogniv enables healthcare systems to leverage the latest developments in artificial intelligence to reduce costs and improve the quality of care.

ClinOS™

A new platform for a new generation of medical tools

AI has the potential to disrupt virtually every facet of medical care. To power this transformation, Biocogniv has developed ClinOS™, a secure and compliant platform that can deliver any AI model to virtually any hospital EHR.

Backed by the best

From the National Institutes of Health and the National Science Foundation to the startup accelerator Y Combinator, our R&D and engineering are backed by top institutions in science and technology.

From the frontlines

“Biocogniv's platform is a key enabler for laboratories to deliver value above and beyond commodity test results. We are excited to partner with Biocogniv and scale out our capabilities.”

Peter McCaffrey, MD FCAP

Director, Lab Information Services
Director, Pathology Informatics
UTMB, TX

“Our collaboration with Biocogniv has led to a powerful demonstration of the utility of AI in medicine, showing how one can predict COVID infection by analyzing blood tests we routinely order.”

Vic Tapson, MD FCCP FRCP

Associate Director
Pulmonary and Critical Care Division
Cedars-Sinai Medical Center, CA

“AI-COVID could be extremely useful for hospitals because it only uses commonly collected blood tests to give meaningful information on a patient's likelihood of testing positive with molecular tests.”

Tim Plante, MD MHS

Department of Medicine
Larner College of Medicine at the University of Vermont, VT

Introducing AI-COVID™

In response to the global pandemic, Biocogniv developed the world's first AI model for predicting the likelihood of COVID-19 infection using only routine blood tests.

Press coverage